Local tumor progression following lipiodol-based targeted chemoembolization of hepatocellular carcinoma: a retrospective comparison of miriplatin and epirubicin

PURPOSE: We aimed to compare the local control rates between miriplatin and epirubicin in lipiodol-based transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). PATIENTS AND METHODS: Patients who underwent targeted TACE using miriplatin (47 patients, 66 lesions) or epirubicin (64...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwazawa, Jin, Ohue, Shoichi, Hashimoto, Naoko, Mitani, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346199/
https://www.ncbi.nlm.nih.gov/pubmed/22570565
http://dx.doi.org/10.2147/CMAR.S30431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346199/
https://www.ncbi.nlm.nih.gov/pubmed/22570565
http://dx.doi.org/10.2147/CMAR.S30431

Ejemplares similares